Patent ID: 6809116
Filing Date: 2004-10-26
Classification: A61K,A61P,C07C

Abstract:
A method for treating a disease state which can be improved by a serotonin reuptake inhibitor wherein said method comprises administering, to an individual in need of such treatment, a compound, or salt thereof, wherein said compound has the following structure: R1 and R2 are independently H, C1-10 alkyl, or R1 and R2 are methylene groups that are part of a cyclic structure; Y is OR3, where R3 is a linear or branched alkyl group having 1 to 12 carbon atoms, or R3 is benzyl, substituted benzyl, aryl, heteroaryl, substituted aryl, or substituted heteraryl; X is fluoro, chloro, iodo, trifluoromethyl, methoxy, cyano, nitro, amino, mono- or di-substituted amino, carboxamide, carboxylic acid, carboxylic ester, sulfonic acid, methyl sulfonate, or sulfonamide; and wherein said disease state is selected from the group consisting of depression, obsessive compulsive disorders and premature ejaculation.